tm logo

Monitor this mark

View On USPTO

NUWIQ
Live/Registered
SECTION 71 ACCEPTED

on 25 Sep 2024

Last Applicant/ Owned by

Octapharma AG

Seidenstrasse 2

Lachen

CH

CH8853

Serial Number

79138098 filed on 09th Aug 2013

Registration Number

4496748 registered on 18th Mar 2014

in the Principal Register

Correspondent Address

Rebecca A. Liebowitz

Rebecca A. Liebowitz VENABLE LLP

Washington, DC 20043

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

NUWIQ

Pharmaceutical products, namely blood coagulation factors, particularly recombinant factors VIII

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical products, namely blood coagulation factors, particularly recombinant factors VIII

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79138098

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 37385-515599

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
25th Sep 2024NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
25th Sep 2024REGISTERED-SEC.71 ACCEPTED
23rd Sep 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
12th Jan 2024TEAS SECTION 71 RECEIVED
10th Aug 2023INTERNATIONAL REGISTRATION RENEWED
18th Mar 2023COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
11th Apr 2020NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
10th Apr 2020REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
01st Apr 2020CASE ASSIGNED TO POST REGISTRATION PARALEGAL
14th Feb 2020TEAS SECTION 71 & 15 RECEIVED